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Purpose: To clarify age-related structural changes specific to hippocampal volume by 
hierarchizing according to age, gender, and menopausal status. Many studies report the 
neuroprotective effects of estrogen and age-related brain volume changes; however, 
there are no studies regarding age-related change specific to hippocampal volume in 
terms of age, gender, and menopausal status.  
Materials and Methods: T1-weighted magnetic resonance images were obtained in 
412 healthy adults divided into 8 groups according to age and gender, to analyze brain 
volume change focusing on hippocampal volume. 
Results: Voxel-based morphometry (VBM) revealed significantly smaller gray matter 
volume in the hippocampus bilaterally in females aged in their fifties (51 of 59 females 
were at menopause) compared with females in their forties (3 of 46 females were at 
menopause). No significant difference was found, however, between female groups in 
their fifties vs. sixties, or sixties vs. seventies; or between male groups in their forties vs. 
fifties, fifties vs. sixties, or sixties vs. seventies. In addition, VBM revealed significant 
hippocampal volume reduction bilaterally in all post-menopausal women compared 
with all pre-menopausal women. 
Conclusion: The results of the current study suggest that the menopause may be 




Many studies report the neuroprotective effects of estrogen and describe the relation 
between estrogen therapy and hippocampal volume (1), the association between 
hippocampal glucose metabolism and cerebrospinal fluid 17β-estradiol concentration in 
post-menopausal women (2), the lower risk of incident Alzheimer’s disease in post-
menopausal women using estrogen (3), and atrophy of hippocampal volume in patients 
with Alzheimer’s disease (4). However, some studies have suggested otherwise (5–8). 
For example, Low et al. reported that no differences were observed between the control 
group and the hormone replacement therapy (HRT) group in terms of total gray matter, 
white matter, hippocampal or amygdalar volumes, severity or volume of white matter 
hyperintensities, or in different measures of brain atrophy (5). Furthermore, the 
neuroprotective role of estrogen remains a controversial issue because analytical results 
are influenced by the type of menopause (i.e., surgical menopause and natural 
menopause) and the type of cognitive test (i.e., verbal, visual and other memory) (9). 
Numerous studies have investigated age-related structural brain changes using MRI, 
showing a negative correlation between gray matter volume and age, predominantly in 
the frontal lobes (10–15). These studies reported that the rate of brain volume decline 
differed according to the focal region and gender (11,13,16–20), as well as a negative 
correlation between hippocampal volume and age (12,20,21); however, to the best of 




The aim of the present study was to investigate hippocampal volume change in 
normal adults divided into eight groups according to their age and gender, using high 
spatial resolution T1-weighted images with 3.0 tesla (3.0-T) magnetic resonance 
scanners and voxel-based morphometry (VBM) (22). In addition, we compared 
hippocampal volume between the pre-menopausal women and post-menopausal women. 
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MATERIALS AND METHODS 
Subjects 
A total of 470 subjects who visited our hospital for a personal health-screening program 
between October 2006 and March 2007 participated in this study. Subjects with a Mini-
Mental State Examination (23) score of 26 or lower were excluded from this study. We 
were not able to exclude mild cognitive impairment. Age at menopause was obtained 
from all female subjects at interview. The MR images were inspected by a board-
certified radiologist (N.H.), and subjects with the following findings were excluded 
from the study: brain tumors, infarctions, hemorrhage, and white matter lesions graded 
higher than grade 2 of Fazekas’s classification (24). A total of 58 subjects were excluded 
from this study. We divided the remaining 412 subjects into the following groups 
according to age and sex: females aged in their forties (mean ± standard deviation (SD), 
45.1 ± 2.9 years, n = 46), females in their fifties (55.4 ± 2.7 years; n = 59), females in 
their sixties (64.2 ± 2.6 years; n = 49), females in their seventies (74.1 ± 3.0 years; n = 
17), males in their forties (44.9 ± 2.8 years; n = 85), males in their fifties (54.2 ± 3.1 
years; n = 80), males in their sixties (64.8 ± 2.7 years; n = 63), and males in their 
seventies (73.6 ± 3.0 years; n = 13). 
Hypertension was defined as maximal blood pressure of 140 mmHg or more, or 
minimal blood pressure of 90 mmHg or more. Drinking index was defined as amount of 
alcohol consumed per day (we assumed 33.6 ml ethanol to be equal to 1, i.e. the volume 
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of ethanol that is approximately equal to one glass of wine) × (number of drinking days 
per week). Smoking index was equal to the Brinkmann index and was expressed as 
(number of cigarettes smoked per day) × (years of smoking). These data and the 
subjects’ characteristics are summarized in Table 1. Although some studies report that 
brain atrophy is associated with hypertension (25–28), alcoholism (29,30), and blood 
glucose level (31–33), subjects were not excluded on the basis of clinical information 
because we did not wish to generate a supernormal group of subjects. Analysis of 
variance (ANOVA) with the Bonferroni–Dunn method as a post hoc test was used to 
compare drinking index, smoking index, and blood glucose level among the groups. The 
Kruskal–Wallis test was used to compare the number of subjects with hypertension 
among the age groups. In both tests, statistical significance was set as P value < 0.05. 
The protocol was approved by the Ethics Committee of our institution. After the study 
had been explained to each subject, written informed consent was obtained from all 
participants. 
 
MRI Scanning Protocol 
MRI data were obtained using a 3.0-T scanner (Signa Excite HDx, GE Medical Systems, 
Waukesha, WI). An 8-channel phased-array brain coil was used as the receiver coil. 
Three-dimensional fast spoiled-gradient recalled acquisition in the steady state (3D-
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FSPGR) was used to obtain 180 contiguous sagittal T1-weighted images with a slice 
thickness of 1.0 mm for VBM analysis (TR / TE = 5.3 / 1.8 ms; inversion time = 450 
ms; flip angle = 15°; field of view = 24 cm; number of excitations = 0.5; 256 × 256 
pixel matrix). The voxel dimensions were 0.9375 × 0.9375 × 1.0 mm. An acceleration 
factor of R = 2.0 was employed for parallel imaging using the Array Spatial Sensitivity 
Encoding Technique. 
 
Image Preprocessing for VBM 
We used Statistical Parametric Mapping 5 (SPM5) software (Wellcome Department of 
Imaging Neuroscience Group, London, UK; http://www.fil.ion.ucl.ac.uk/spm) (34). The 
3D-FSPGR images in native space were bias-corrected, spatially normalized, and 
segmented into gray matter, white matter, and cerebrospinal fluid images (22); voxel 
size of the normalized images was 2 × 2 × 2 mm. The affine regularization space 
template from the International Consortium for Brain Mapping was changed from the 
European to the East Asian brain template. During the modulation step, the voxel values 
of the normalized gray and white matter images were multiplied by a measure of the 
relative volumes of the warped and unwarped structures derived from the nonlinear step 
of spatial normalization using the Jacobian determinant. The total gray and white matter 
volume, and the total intracranial volume (TIV; measured in ml) were computed by 
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multiplying the voxel value by the voxel volume and summing the results for all voxels. 
The resulting gray matter images were smoothed with a Gaussian kernel of 6 mm full 
width at half-maximum. 
 
Statistical Analyses for VBM 
The normalized data smoothed with 6-mm isotropic Gaussian kernels were analyzed 
with SPM5 employing the framework of the general linear model. Statistical 
significance for gray matter volume between the paired sequential age groups (subjects 
in their forties vs. fifties, fifties vs. sixties, sixties vs. seventies) of both males and 
females was tested with TIV as the confounding covariate to control for brain volume 
differences between subjects. To test hypotheses with respect to regionally specific 
group effects, the estimates were compared with two linear contrasts (increased or 
decreased gray matter volume). The significance of each region was estimated by 
distributional approximations from the theory of random Gaussian fields. A P value of 
less than 0.05 corrected with family-wise error (FWE) in voxel difference and a cluster 
size greater than 30 voxels was considered to be statistically significant. 
In addition, regional gray matter volume of the group of all pre-menopausal women 
(mean ± SD, 45.8 ± 3.6 years; n = 51) was compared with that of all post-menopausal 
women (61.3 ± 6.7 years; n = 120) in a voxel-wise manner to avoid type 1 or type 2 
error due to multiple pairs of group comparisons (e.g. forties vs. fifties, fifties vs. sixties, 
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sixties vs. seventies for each sex). Because we hypothesized that menopause might have 
a certain effect on hippocampal volume, we employed small-volume correction for 
multiple comparisons (20 × 30 × 26-mm regions at center (± 26, –24, –8)) (35). We 
treated age and TIV as confounding covariates, in this analysis. Previous neuroimaging 
studies reported that hippocampal volume negatively correlates. We treated age as a 
confounding covariate to control for age-related volume changes because subjects with 
a wide range of age were enrolled in this analysis. A P value of less than 0.05 corrected 






ANOVA revealed no significant differences in drinking index (P = 0.120), smoking 
index (P = 0.204), or blood glucose level (P = 0.286) among the female groups; or in 
smoking index (P = 0.948) or blood glucose level (P = 0.064) among the male groups. 
There was significant difference in drinking index (P = 0.014) among the male groups 
tested with ANOVA. Significant difference was found in drinking index only between 
the groups of males in their forties vs. sixties (P = 0.004) with a post hoc test. Kruskal–
Wallis test revealed no significant difference in the number of subjects with 
hypertension among the female groups (P = 0.391) or the male groups (P = 0.061). 
 
Differences in Gray Matter Volume Using VBM  
Bilateral hippocampal volumes were significantly smaller for females in their fifties 
than in their forties (Fig. 1). Montreal Neurological Institute (MNI) coordinates of local 
maxima were 26, –24, –18 (max P value < 0.001, T value = 6.96, cluster size = 208) for 
the right hippocampus, and –28, –22, –18 (max P value < 0.001, T value = 6.16, cluster 
size = 161) for the left hippocampus. There was no significant difference in 
hippocampal volume between the female groups in fifties vs. sixties, sixties vs. 
seventies, or the male groups in forties vs. fifties, fifties vs. sixties, or sixties vs. 
seventies. In addition, regional gray matter volume in the group of all pre-menopausal 
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women was compared with that of all post-menopausal women in a voxel-wise manner. 
Significant hippocampal volume reduction was found bilaterally in the post-menopausal 
group compared with the pre-menopausal group, in good agreement with the results of 
group comparison between females in their forties vs. fifties. MNI coordinates of local 
maxima were 26, –26, –18 (max P value = 0.031, T value = 4.51) for the right 






In the present study, voxel-wise comparison revealed that gray matter volumes in the 
bilateral hippocampus were significantly smaller in females in their fifties (51 of 59 
females were at menopause) than in their forties (only 3 of the 46 females were at 
menopause). In addition, a significantly smaller hippocampus was found in the post-
menopausal group than in the pre-menopausal group. The significant volume reduction 
found in females in their fifties might have type 1 or type 2 errors due to multiple pairs 
of group comparisons; however, the significant volume reduction found in the post-
menopausal group did not suffer from type 1 or type 2 errors because no multiple 
comparisons were made. Furthermore, these results were consistent, and 
complementary to each other. To the best of our knowledge, no previous studies have 
compared hippocampal volume change in detail according to age and sex. In our study, 
it is not clear that post-menopause women show faster age-related effects than the pre-
menopause women or that there is a sudden drop in hippocampus volume after 
menopause. We expect that it be clarified by longitudinal study in future investigation. 
Many studies have reported a negative correlation between gray matter volume and 
age, while others have reported that the rate of decline of brain volume differs according 
to the focal region and sex (11,16-20). Several studies reported findings consistent with 
age-related reduction in hippocampal volume; however, these reports did not consider 
the rate of decline between groups divided according to age. 
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In the present study, hippocampal volume measurements revealed a significant 
difference bilaterally between the groups of females in their forties vs. fifties; there was 
no significant difference between the groups of females in their fifties vs. sixties, or in 
their sixties vs. seventies. We consider that the reason for this discrepancy is that 
reduced hippocampal volume over one decade was so small compared to the SD in each 
group that a statistically significant reduction was not found in group comparisons. 
Previous longitudinal studies indicate that the process of atrophy differs among 
individuals (36,37). In other words, within-group variance in people in their forties and 
fifties is lower than that in people in their sixties and seventies; i.e., comparison of data 
between people in their sixties and seventies is more insensitive to change than 
comparison between data of those in their forties and fifties. We were not able to 
eliminate this problem; however, significant difference was found in brain volume 
between the female groups in their forties and fifties but not between the male groups in 
their forties and fifties. We think that the different results between the sexes could be 
indirect evidence of the effects of menopause on hippocampal volume. Several studies 
report various rates of hippocampal volume reduction (12,19,20,38) because the rate of 
reduction might be affected by varying factors in the studies (age range, male–female 
ratio, ROI, etc.). Therefore, we must interpret the results of the rate of hippocampal 
volume reduction quantitatively and with much caution. 
Lord et al. studied the relation between estrogen therapy and hippocampal volume in 
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estrogen therapy users, past users, never users, and men, and suggested a positive 
association between estrogen and hippocampal volume (1). In a study that measured the 
17β-estradiol levels in cerebrospinal fluid (CSF) and regional cerebral (18F) 2-fluoro 2-
deoxy–D-glucose uptake in six female post-menopausal patients with probable 
Alzheimer’s disease (mean age = 70.3 ± 7.7 years, age range = 68–78 years), 
Schonknecht et al. suggested an association between estrogen and hippocampal glucose 
metabolism (2). Tang et al. reported that estrogen use in post-menopausal women might 
delay the onset and decrease the risk of Alzheimer’s disease (3) by the neuroprotective 
effect of estrogen (9,39). In contrast, Amagai et al. studied 4683 females (age range = 
36–89 years) and reported the mean age ± SD at menopause as 48.3 ± 4.8, with 80% of 
females experiencing menopause between 45 and 54 years of age (40). Furthermore, in 
the present study, only 3 of 46 females in their forties were at menopause, while 51 of 
59 females in their fifties were at menopause. Therefore, we speculate that the reduced 
estrogen levels in post-menopausal women might accelerate the rate of decline in 
hippocampal volume through forty and fifty years old.  
A major limitation of the current study is the lack of information regarding estrogen 
levels in the blood and in CSF. Unfortunately, because estrogen level was not measured 
as part of our hospital’s personal health screening program, we are not able to infer a 
direct relationship between estrogen level and hippocampal volume. However, previous 
reports indicate that the prevalence of HRT use in Japan is approximately 2% (41). 
16 
 
Therefore, we consider that HRT would have had very little effect on the present results.  
Previous studies report that as well as estrogen level, hypertension (15,25–28), 
drinking index (29,30), smoking index (42,43), and blood glucose level (31–33) have a 
certain effect on brain volume. We consider, however, that these additional factors 
would have had very little effect on the present analysis because we found no significant 
difference in hypertension, drinking index, smoking index, or blood glucose level 
among the female groups. Furthermore, significant difference was found in brain 
volume between the female groups in their forties and fifties but not between the male 
groups in their forties and fifties. We think that these different results between the sexes 
could be indirect evidence of menopausal effects on hippocampal volume, and we 
therefore speculate that the reduction in estrogen levels in post-menopausal women 
accelerates the rate of hippocampal volume decline in the female group in their fifties 
compared to that in their forties. However, to confirm our prediction, we consider that 
future investigation is needed, using information regarding estrogen levels and HRT. 
The second limitation of our study was that a significant difference in drinking index 
was found only between the groups of males in their forties vs. sixties. This result 
suggests that alcohol consumption affects age-related reduction of hippocampal volume 
and could cause overestimation of the rate of hippocampal volume reduction in males 
from a quantitative viewpoint; however, a significant difference in drinking index was 
not seen in the results of female group differences between the forties and fifties. To 
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investigate the effect of alcohol intake on brain volume, we tested correlations between 
gray matter volume and drinking index in a voxel-wise manner, treating age and TIV as 
confounding covariates among all subjects. The results revealed no significant 
correlation between hippocampal volume and drinking index. Therefore, a significant 
difference in drinking index between the groups of males in their forties vs. sixties had a 
minor effect on our morphometric results. 
Although hypertension was more prevalent in the older groups, there was no 
significant difference in the number of persons with hypertension among the female 
groups or the male groups. Therefore, we did not exclude subjects on the basis of 
hypertension or drinking because we thought that these factors would have very little 
effect on the volumetric findings, and we did not wish to generate a supernormal group 
of subjects. Because we considered influence from third variables, we tried to exclude 
the influence of various factors (i.e., hypertension, drinking index, smoking index, and 
blood glucose level); however, we consider that influence from other variables may not 
have been completely excluded. Therefore, the results of the present study need to be 
interpreted with caution because third variables may explain the group differences. 
We performed an additional ROI study using linear regression and polynomial 
correlation analyses. These results showed a negative correlation between gray matter 
volume and age, but were not able to prove a difference within the critical age window 
for menopausal status; however, when groups were divided according to age and sex, 
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we detected accelerated reduction in the group of females in their forties compared with 
fifties. It is arbitrary to group the subjects by decades of age, but correlational analyses 
(such as linear, polynomial, and logarithmic regression) may not enable detection of 
volume changes at specific decades of age. In other words, using this method of 
analysis, we could detect accelerated volume changes in the hippocampus between 
women in their forties and fifties, but not in other decades. Furthermore, because we 
treated age as a confounding covariate in our analysis, age-related volume change could 
be controlled. 
In conclusion, VBM revealed significant hippocampal volume reduction only 
between groups of females in their forties vs. fifties. A similar reduction was found 
between the pre-menopausal and post-menopausal groups. The results of the current 
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Table 1 Subjects data
female
forties 46 3 45.1 ± 2.9 45.7 ± 2.9 4 3.05 ± 6.21 83.8 ± 181.3 91.3 ±   7.8
fifties 59 51 55.4 ± 2.7 50.6 ± 3.1 8 1.85 ± 3.25 58.7 ± 190.4 95.2 ± 11.5
sixties 49 49 64.2 ± 2.6 50.7 ± 4.3 10 1.07 ± 2.54 15.7 ±   63.6 93.8 ±   9.3
seventies 17 17 74.1 ± 3.0 49.6 ± 3.6 6 1.34 ± 3.16 83.2 ± 228.5 93.4 ± 12.5
forties 85 - 44.9 ± 2.8 - 9 10.36 ± 9.55 489.0 ± 384.5 101.1 ± 15.7
fifties 80 - 54.2 ± 3.1 - 23   7.15 ± 7.92 470.0 ± 515.0 109.8 ± 31.9
sixties 63 - 64.8 ± 2.7 - 18   6.39 ± 7.28 449.2 ± 497.8 101.5 ± 16.0











































Age, age at menopause, drinking index, smoking index, and blood glucose level are 
shown as average ± standard deviation. 
Hypertension was defined as maximal blood pressure≧140mmHg or minimal blood 
pressure≧90mmHg. 
Drinking index was defined as (amount of alcohol consumed per day) × (number of 
drinking days per week). 
Smoking index was equal to the Brinkmann index and was expressed as (number of 








Figure 1. Areas of decreased gray matter volume between females in their forties vs. 
fifties. Regions of gray matter volume difference are superimposed onto the T1 template 
image. The color bar (bottom right) represents the T score. R and L indicate the right 
and left sides of the subjects, respectively. Right hippocampus: max T value = 6.96, 
cluster size = 208, (x, y, z) = (26, –24, –18). Left hippocampus: max T value = 6.16, 
cluster size = 161, (x, y, z) = (–28, –22, –18). 
